Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dorzagliatin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin
    Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin

    26 Sep 2021

    // SCOOP

    https://www.scoop.co.nz/stories/GE2109/S00183/researchers-present-key-research-results-on-diabetes-remission-of-dorzagliatin.htm

    SCOOP
    26 Sep 2021
    Share Share
    Hua Medicine, Bayer bring novel diabetes treatment in China
    Hua Medicine, Bayer bring novel diabetes treatment in China

    19 Aug 2020

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/16551/hua-medicine-bayer-bring-novel-diabetes-treatment-in-china.html

    BIOSPECTRUMASIA
    19 Aug 2020
    Share Share
    Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin
    Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin

    02 Jul 2020

    // ACNNEWSWIRE

    https://www.acnnewswire.com/press-release/english/59982/hua-medicine-announces-positive-24-week-topline-results-of-phase-iii-metformin-combination-trial-of-dorzagliatin

    ACNNEWSWIRE
    02 Jul 2020
    Share Share
    Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin
    Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin

    27 Apr 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/04/27/2022101/0/en/Hua-Medicine-Announces-Positive-Results-of-the-Combination-Study-of-Dorzagliatin-with-Empagliflozin-a-SGLT-2-inhibitor.html

    GLOBENEWSWIRE
    27 Apr 2020
    Share Share
    ARCH-backed Chinese biotech scores PhIII win for glucokinase diabetes drug
    ARCH-backed Chinese biotech scores PhIII win for glucokinase diabetes drug

    13 Nov 2019

    // Amber Tong ENDPTS

    https://endpts.com/arch-backed-chinese-biotech-scores-phiii-win-for-glucokinase-modulating-diabetes-drug/

    Amber Tong ENDPTS
    13 Nov 2019
    Share Share
    Hua Medicine reaps $110.5M, adjusting expectations for Hong Kong IPO
    Hua Medicine reaps $110.5M, adjusting expectations for Hong Kong IPO

    15 Sep 2018

    // Amber Tong ENDPTS

    https://endpts.com/hua-medicine-reaps-110-5m-adjusting-expectations-for-hong-kong-ipo/?utm_medium=email&utm_campaign=565%20Fri%2091418%20Allergan%20shells%20out%20195M-plus%20for%20a%20rival%20biotech%20Should%20Jos%20Baselga%20have%20been%20forced%20out%20at%20Memorial%20Sloan%20Kettering&utm_content=565%20Fri%2091418%20Allergan%20shells%20out%20195M-plus%20for%20a%20rival%20biotech%20Should%20Jos%20Baselga%20have%20been%20forced%20out%20at%20Memorial%20Sloan%20Kettering+CID_987373a0b5ef2e7493e004a13d237bc2&utm_source=ENDPOINTS%20emails&utm_term=Hua%20Medicine%20reaps%201105M%20adjusting%20expectations%20for%20Hong%20Kong%20IPO

    Amber Tong ENDPTS
    15 Sep 2018
    Share Share